Brain images from FDG-PET can help detect Alzheimer’s disease in patients presenting with focal onset dementias.
Images of the brain using FDG-PET can accurately detect Alzheimer's disease in patients presenting with primary progressive aphasia or corticobasal syndrome as focal onset dementias, according to a study published in The Journal of Nuclear Medicine.
Authors from the United States, Japan, and Australia sought to determine the accuracy of FDG-PET metabolic imaging when detecting Alzheimer’s disease among patients with primary progressive aphasia or corticobasal syndrome.
A total of 94 subjects participated in the study, including subjects who were diagnosed with:
• Logopenic aphasia, 19 subjects
• Non-fluent aphasia, 16 subjects
• Semantic aphasia, 13 subjects[[{"type":"media","view_mode":"media_crop","fid":"41084","attributes":{"alt":"PET CT","class":"media-image media-image-right","id":"media_crop_6997834934021","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4285","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 113px; width: 151px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]
• Corticobasal syndrome, 14 subjects
• Alzheimer's disease, 24 subjects
All underwent F18-FDG metabolic and C11-PiB amyloid PET brain imaging. The FDG-PET scans that were read with Neurostat 3D-SSP software displays were classified as Alzheimer's disease or other by readers blind to the clinical assessments and PiB-PET results.
The results showed 84% accuracy for subjects who were diagnosed with Alzheimer’s disease based on FDG-PET results. However, diagnoses based on clinical assessment resulted in only 65% conventional and 67% balanced accuracy.
The researchers concluded, “Brain FDG-PET scans read with Neurostat 3D-SSP displays accurately detect Alzheimer's disease in patients presenting with primary progressive aphasia or corticobasal syndrome as focal onset dementias. In these diagnostically challenging cohorts, FDG-PET imaging can provide more accurate diagnoses enabling more appropriate therapy.”
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
FDA Clears AI Assessment of Ischemic Core Volume on CT with Brainomix 360 Platform
April 8th 2025For patients with acute ischemic stroke, research has demonstrated that automated assessment of ischemic core volume on brain CT scans via the Brainomix 360 software is equivalent to that derived from CT perfusion.